Race Immunotherapeutics

Race Immunotherapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Joint Venture
  • Financing Rounds
  • 1

Race Immunotherapeutics General Information

Description

Developer of cancer therapies intended to provide treatment to cancer patients. The company's cancer therapies focus on a combination of drugs equipped with advanced technological innovations, enabling doctors and physicians to provide comprehensive and effective treatments to patients suffering from cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
  • Basel
  • Switzerland
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Race Immunotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Race Immunotherapeutics‘s full profile, request access.

Request a free trial

Race Immunotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Race Immunotherapeutics‘s full profile, request access.

Request a free trial